UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $360.00 (from $280.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

BNP Paribas Exane Eaton (ETN): 'we revisited our model and conclude our DC revenue CAGR of >20% through 2030 is achievable'September 12, 2025 10:02 AM DA Davidson on Oracle (ORCL): 'We believe OpenAI will continue to be a key winner from the explosion of growth in AI'September 11, 2025 11:19 AM Oppenheimer Keeps Perform Rating on Oracle (ORCL): 'a step-up in Capex expense to support the RPO growth is consuming all the free cash flow generation'September 10, 2025 6:32 AM